Compound ID | 3575
SPR113
Synonym(s): SPR-113 | SPR 113
| Details of activity: | Active against multidrug-resistant and extensively-resistant Mycobacterium tuberculosis |
| Description: | Shows efficacy in treating Mycobacterium tuberculosis infection in human macrophages and murine model; shows no activity against cytochrome P-450 and hERG (high selectivity) |
| Institute where first reported: | Sphaera Pharma and the Drug Discovery Research Centre (DDRC) of the Translational Health Science and Technology Institute, India |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.